309 related articles for article (PubMed ID: 27877089)
21. Cisplatin induces stemness in ovarian cancer.
Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
[TBL] [Abstract][Full Text] [Related]
22. Suppression of ES cell differentiation by retinol (vitamin A) via the overexpression of Nanog.
Chen L; Yang M; Dawes J; Khillan JS
Differentiation; 2007 Oct; 75(8):682-93. PubMed ID: 17451418
[TBL] [Abstract][Full Text] [Related]
23. Sp5 induces the expression of Nanog to maintain mouse embryonic stem cell self-renewal.
Tang L; Wang M; Liu D; Gong M; Ying QL; Ye S
PLoS One; 2017; 12(9):e0185714. PubMed ID: 28961274
[TBL] [Abstract][Full Text] [Related]
24. The pluripotency transcription factor Nanog represses glutathione reductase gene expression in mouse embryonic stem cells.
Solari C; Petrone MV; Toro A; Vazquez Echegaray C; Cosentino MS; Waisman A; Francia M; Barañao L; Miriuka S; Guberman A
BMC Res Notes; 2019 Jul; 12(1):370. PubMed ID: 31262352
[TBL] [Abstract][Full Text] [Related]
25. BRD4 regulates Nanog expression in mouse embryonic stem cells and preimplantation embryos.
Liu W; Stein P; Cheng X; Yang W; Shao NY; Morrisey EE; Schultz RM; You J
Cell Death Differ; 2014 Dec; 21(12):1950-60. PubMed ID: 25146928
[TBL] [Abstract][Full Text] [Related]
26. NANOG: a promising target for digestive malignant tumors.
Sun AX; Liu CJ; Sun ZQ; Wei Z
World J Gastroenterol; 2014 Sep; 20(36):13071-8. PubMed ID: 25278701
[TBL] [Abstract][Full Text] [Related]
27. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
[TBL] [Abstract][Full Text] [Related]
28. Stem cell transcription factor NANOG in cancers--is eternal youth a curse?
Wong OG; Cheung AN
Expert Opin Ther Targets; 2016; 20(4):407-17. PubMed ID: 26634876
[TBL] [Abstract][Full Text] [Related]
29. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
[TBL] [Abstract][Full Text] [Related]
30. Perspective: Cooperation of Nanog, NF-κΒ, and CXCR4 in a regulatory network for directed migration of cancer stem cells.
Es-Haghi M; Soltanian S; Dehghani H
Tumour Biol; 2016 Feb; 37(2):1559-65. PubMed ID: 26715265
[TBL] [Abstract][Full Text] [Related]
31. Unravelling evolution of Nanog, the key transcription factor involved in self-renewal of undifferentiated embryonic stem cells, by pattern recognition in nucleotide and tandem repeats characteristics.
Pashaiasl M; Khodadadi K; Kayvanjoo AH; Pashaei-Asl R; Ebrahimie E; Ebrahimi M
Gene; 2016 Mar; 578(2):194-204. PubMed ID: 26687709
[TBL] [Abstract][Full Text] [Related]
32. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
33. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
34. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.
Yao C; Su L; Shan J; Zhu C; Liu L; Liu C; Xu Y; Yang Z; Bian X; Shao J; Li J; Lai M; Shen J; Qian C
Stem Cells; 2016 Apr; 34(4):820-31. PubMed ID: 26840943
[TBL] [Abstract][Full Text] [Related]
35. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.
Fong H; Hohenstein KA; Donovan PJ
Stem Cells; 2008 Aug; 26(8):1931-8. PubMed ID: 18388306
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Human Stem Cell Transcription Factors.
Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
[TBL] [Abstract][Full Text] [Related]
37. Nanog promotes stem-like traits of glioblastoma cells.
Yuan Y; Zhang M; Yan G; Ma Q; Yan Z; Wang L; Yang K; Guo D
Front Biosci (Landmark Ed); 2021 Jan; 26(3):552-565. PubMed ID: 33049683
[TBL] [Abstract][Full Text] [Related]
38. Cell-permeant recombinant Nanog protein promotes pluripotency by inhibiting endodermal specification.
Peitz M; Münst B; Thummer RP; Helfen M; Edenhofer F
Stem Cell Res; 2014 May; 12(3):680-9. PubMed ID: 24681518
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of p53 suppresses Nanog expression in embryonic stem cells.
Abdelalim EM; Tooyama I
Biochem Biophys Res Commun; 2014 Jan; 443(2):652-7. PubMed ID: 24333425
[TBL] [Abstract][Full Text] [Related]
40. New insight into NANOG: A novel therapeutic target for ovarian cancer (OC).
Mahalaxmi I; Devi SM; Kaavya J; Arul N; Balachandar V; Santhy KS
Eur J Pharmacol; 2019 Jun; 852():51-57. PubMed ID: 30831081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
